Navigation Links
New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses

PALO ALTO, Calif., Aug. 24 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) introduced its new dual wavelength X-ray diffractometer for the analysis of small molecules and proteins. The SuperNova(TM) is the first dual wavelength diffraction system to use entirely high intensity micro-source X-ray technology. It includes innovations in both X-ray technology and data analysis, enabling faster results even for the most challenging crystals.

Single crystal X-ray diffraction is used to determine the structure of small molecules and proteins at high resolution. Applications include chemistry, geology, physics, structural biology and pharmaceutical research. The trend in crystallography is towards the ability to analyze smaller, poorer crystal samples and to increase the speed of sample throughput. The significant improvement in the intensity of X-ray radiation placed on the sample from the dual Nova(TM) and Mova(TM) X-ray micro-sources makes both higher resolution and higher throughput possible.

The system is ideal for the study of challenging samples in small molecule and protein crystallography. It includes co-mounted, dual wavelength and high intensity X-ray micro-sources of both molybdenum and copper wavelength. It is the first dual wavelength system incorporating purely high intensity Mo and Cu micro-source X-ray technology.

The system improves throughput in several ways. The high intensity X-ray radiation allows for shorter X-ray exposure, as does the high sensitivity, large area Atlas CCD (charge-coupled device). Both enable faster data collection. In addition, the duty cycle (the dead time required for the CCD detector to transfer data to the computer), has been substantially reduced. As important, the AutoChem software automates crystal structure solution, refinement and report generation. Data analysis is concurrent with data collection, significantly reducing the time spent by the user to solve and refine the crystal structure.

"The SuperNova allows for high-throughput, information-rich, X-ray analysis of proteins and small molecules," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "This solution complements our NMR products, strengthening our strategy of giving our customers ease of use while gathering extremely detailed structural information on large numbers of samples."

For more technical information about Varian's X-ray diffraction products, please visit

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 4,000 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site:

For More Information, Contact:

Public Relations

Varian, Inc.


SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
2. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
3. Faster X-ray interferometers due to single-photon interference
4. Super-resolution X-ray microscopy
5. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
6. Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
7. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
8. Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
9. Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe
10. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
11. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
Post Your Comments:
(Date:11/30/2015)... includes an MPP licen c ... , s Solid Drug Nanoparticle (SDN) Technology ; Aims ... through cost cuts of priority ... anywhere in the world will have the right to make, use and distribute lower ... licensees based anywhere in the world will have the right to make, use and ...
(Date:11/30/2015)... Md. , Nov. 30, 2015 ... development company committed to the fostering and monetization ... the current and prospective initiatives designed to create ... Chief Executive Officer of Spherix. "Based on published ... future licensees exceeds $50 billion and Spherix will ...
(Date:11/30/2015)... 2015 TapImmune, Inc. (TPIV), ... innovative peptide and gene-based immunotherapeutics and vaccines for the ... will be presenting at the 8 th Annual ... 2.30 PM PT. Dr. John N. Bonfiglio ... giving the presentation and will join TapImmune management in ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December ... (ECNR) in Vienna, Austria to ... wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), ... NovaVision Therapy Suite at the 3rd European Congress of ...
Breaking Biology Technology:
(Date:11/19/2015)... Nov. 19, 2015  Although some 350 companies are ... by a few companies, according to Kalorama Information. These include ... of the market share of the 6.1 billion-dollar molecular ... World Market for Molecular Diagnostic s .    ... is still controlled by one company and only a ...
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
Breaking Biology News(10 mins):